{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T07:53:06Z","timestamp":1761897186003,"version":"3.37.3"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2019,12,13]],"date-time":"2019-12-13T00:00:00Z","timestamp":1576195200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,12,13]],"date-time":"2019-12-13T00:00:00Z","timestamp":1576195200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100003478","name":"Ministry of Health, Labour and Welfare","doi-asserted-by":"publisher","award":["H22-AIDS-I-002","H25-AIDS-I-002"],"award-info":[{"award-number":["H22-AIDS-I-002","H25-AIDS-I-002"]}],"id":[{"id":"10.13039\/501100003478","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["18fk0410008h003","15Afk0410004h0003"],"award-info":[{"award-number":["18fk0410008h003","15Afk0410004h0003"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Hematol"],"published-print":{"date-parts":[[2020,3]]},"DOI":"10.1007\/s12185-019-02791-y","type":"journal-article","created":{"date-parts":[[2019,12,13]],"date-time":"2019-12-13T09:04:46Z","timestamp":1576227886000},"page":"434-439","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Autologous peripheral blood stem cell transplantation for relapsed\/refractory HIV-associated lymphoma: a phase II clinical study"],"prefix":"10.1007","volume":"111","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0811-331X","authenticated-orcid":false,"given":"Shotaro","family":"Hagiwara","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hirokazu","family":"Nagai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomoko","family":"Uehira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akiko M.","family":"Saito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seiji","family":"Okada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,12,13]]},"reference":[{"key":"2791_CR1","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1111\/ejh.13082","volume":"101","author":"A Meister","year":"2018","unstructured":"Meister A, Hentrich M, Wyen C, Hubel K. Malignant lymphoma in the HIV-positive patient. Eur J Haematol. 2018;101:119\u201326.","journal-title":"Eur J Haematol."},{"key":"2791_CR2","doi-asserted-by":"publisher","first-page":"1540","DOI":"10.1056\/NEJM199512073332305","volume":"333","author":"T Philip","year":"1995","unstructured":"Philip T, Guglielmi C, Hagenbeek A, Somers R, Van der Lelie H, Bron D, et al. Autologous bone marrow transplantation as compared with salvage chemotherapy in relapses of chemotherapy-sensitive non-Hodgkin's lymphoma. N Engl J Med. 1995;333:1540\u20135.","journal-title":"N Engl J Med."},{"key":"2791_CR3","first-page":"1195","volume":"18","author":"J Gabarre","year":"1996","unstructured":"Gabarre J, Leblond V, Sutton L, Azar N, Jouan M, Boccaccio C, et al. Autologous bone marrow transplantation in relapsed HIV-related non-Hodgkin's lymphoma. Bone Marrow Transplant. 1996;18:1195\u20137.","journal-title":"Bone Marrow Transplant."},{"key":"2791_CR4","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/S0268-960X(03)00026-2","volume":"17","author":"A Molina","year":"2003","unstructured":"Molina A, Zaia J, Krishnan A. Treatment of human immunodeficiency virus-related lymphoma with haematopoietic stem cell transplantation. Blood Rev. 2003;17:249\u201358.","journal-title":"Blood Rev."},{"key":"2791_CR5","doi-asserted-by":"publisher","first-page":"6011","DOI":"10.1182\/blood-2008-12-195388","volume":"113","author":"JL Diez-Martin","year":"2009","unstructured":"Diez-Martin JL, Balsalobre P, Re A, Michieli M, Ribera JM, Canals C, et al. Comparable survival between HIV+ and HIV- non-Hodgkin and Hodgkin lymphoma patients undergoing autologous peripheral blood stem cell transplantation. Blood. 2009;113:6011\u20134.","journal-title":"Blood"},{"key":"2791_CR6","first-page":"1100","volume":"89","author":"J Gabarre","year":"2004","unstructured":"Gabarre J, Marcelin AG, Azar N, Choquet S, Levy V, Levy Y, et al. High-dose therapy plus autologous hematopoietic stem cell transplantation for human immunodeficiency virus (HIV)-related lymphoma: results and impact on HIV disease. Haematologica. 2004;89:1100\u20138.","journal-title":"Haematologica"},{"key":"2791_CR7","doi-asserted-by":"publisher","first-page":"4423","DOI":"10.1200\/JCO.2003.06.039","volume":"21","author":"A Re","year":"2003","unstructured":"Re A, Cattaneo C, Michieli M, Casari S, Spina M, Rupolo M, et al. High-dose therapy and autologous peripheral-blood stem-cell transplantation as salvage treatment for HIV-associated lymphoma in patients receiving highly active antiretroviral therapy. J Clin Oncol. 2003;21:4423\u20137.","journal-title":"J Clin Oncol."},{"key":"2791_CR8","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1016\/j.exphem.2004.12.008","volume":"33","author":"D Serrano","year":"2005","unstructured":"Serrano D, Carrion R, Balsalobre P, Miralles P, Berenguer J, Bu\u00f1o I, et al. HIV-associated lymphoma successfully treated with peripheral blood stem cell transplantation. Exp Hematol. 2005;33:487\u201394.","journal-title":"Exp Hematol."},{"key":"2791_CR9","doi-asserted-by":"publisher","first-page":"1306","DOI":"10.1182\/blood-2009-02-202762","volume":"114","author":"A Re","year":"2009","unstructured":"Re A, Michieli M, Casari S, Miralles P, Berenguer J, Buno I, et al. High-dose therapy and autologous peripheral blood stem cell transplantation as salvage treatment for AIDS-related lymphoma: long-term results of the Italian Cooperative Group on AIDS and Tumors (GICAT) study with analysis of prognostic factors. Blood. 2009;114:1306\u201313.","journal-title":"Blood"},{"key":"2791_CR10","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.bbmt.2007.03.014","volume":"14","author":"TR Spitzer","year":"2008","unstructured":"Spitzer TR, Ambinder RF, Lee JY, Kaplan LD, Wachsman W, Straus DJ, et al. Dose-reduced busulfan, cyclophosphamide, and autologous stem cell transplantation for human immunodeficiency virus-associated lymphoma: AIDS Malignancy Consortium study 020. Biol Blood Marrow Transplant. 2008;14:59\u201366.","journal-title":"Biol Blood Marrow Transplant."},{"key":"2791_CR11","doi-asserted-by":"publisher","first-page":"1244","DOI":"10.1200\/JCO.1999.17.4.1244","volume":"17","author":"BD Cheson","year":"1999","unstructured":"Cheson BD, Horning SJ, Coiffier B, Shipp MA, Fisher RI, Connors JM, et al. Report of an international workshop to standardize response criteria for non-Hodgkin's lymphomas NCI Sponsored International Working Group. J Clin Oncol. 1999;17:1244.","journal-title":"J Clin Oncol."},{"key":"2791_CR12","doi-asserted-by":"publisher","first-page":"111","DOI":"10.2169\/internalmedicine.48.1295","volume":"48","author":"KC Kawabata","year":"2009","unstructured":"Kawabata KC, Hagiwara S, Takenouchi A, Tanimura A, Tanuma J, Tachikawa N, et al. Autologous stem cell transplantation using MEAM regimen for relapsed AIDS-related lymphoma patients who received highly active anti-retroviral therapy: a report of three cases. Intern Med. 2009;48:111\u20134.","journal-title":"Intern Med."},{"key":"2791_CR13","doi-asserted-by":"publisher","first-page":"1596","DOI":"10.1016\/j.bbmt.2018.03.009","volume":"24","author":"N Yoshinaga","year":"2018","unstructured":"Yoshinaga N, Kanda J, Aisa Y, Hagiwara S, Mori T, Fukuda T, et al. Impact of HIV infection on transplant outcomes after autologous peripheral blood stem cell transplantation: a retrospective study of Japanese registry data. Biol Blood Marrow Transplant. 2018;24:1596\u2013601.","journal-title":"Biol Blood Marrow Transplant."},{"key":"2791_CR14","doi-asserted-by":"publisher","first-page":"2383","DOI":"10.3109\/10428194.2012.697559","volume":"53","author":"UD Bayraktar","year":"2012","unstructured":"Bayraktar UD, Ramos JC, Petrich A, Gupta N, Lensing S, Moore PC, et al. Outcome of patients with relapsed\/refractory acquired immune deficiency syndrome-related lymphoma diagnosed 1999\u20132008 and treated with curative intent in the AIDS Malignancy Consortium. Leuk Lymphoma. 2012;53:2383\u20139.","journal-title":"Leuk Lymphoma."},{"key":"2791_CR15","doi-asserted-by":"publisher","first-page":"4184","DOI":"10.1200\/JCO.2010.28.1618","volume":"28","author":"C Gisselbrecht","year":"2010","unstructured":"Gisselbrecht C, Glass B, Mounier N, Singh Gill D, Linch DC, Trneny M, et al. Salvage regimens with autologous transplantation for relapsed large B-cell lymphoma in the rituximab era. J Clin Oncol. 2010;28:4184\u201390.","journal-title":"J Clin Oncol."},{"key":"2791_CR16","doi-asserted-by":"publisher","first-page":"1829","DOI":"10.3324\/haematol.13440","volume":"93","author":"A Martin","year":"2008","unstructured":"Martin A, Conde E, Arnan M, Canales MA, Deben G, Sancho JM, et al. R-ESHAP as salvage therapy for patients with relapsed or refractory diffuse large B-cell lymphoma: the influence of prior exposure to rituximab on outcome. A GEL\/TAMO study. Haematologica. 2008;93:1829\u201336.","journal-title":"A GEL\/TAMO study. Haematologica."},{"key":"2791_CR17","unstructured":"UNAIDS. UNAIDS Data 2019. https:\/\/www.unaids.org\/sites\/default\/files\/media _asset\/2019-UNAIDS-data_en.pdf. 2019. Accessed 22 Oct 2019."},{"key":"2791_CR18","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1007\/s12185-018-2508-1","volume":"108","author":"Y Kameoka","year":"2018","unstructured":"Kameoka Y, Akagi T, Murai K, Noji H, Kato Y, Sasaki O, et al. Safety and efficacy of high-dose ranimustine (MCNU) containing regimen followed by autologous stem cell transplantation for diffuse large B-cell lymphoma. Int J Hematol. 2018;108:510\u20135.","journal-title":"Int J Hematol."},{"key":"2791_CR19","doi-asserted-by":"publisher","first-page":"1513","DOI":"10.1007\/s00277-016-2740-9","volume":"95","author":"M Sugimoto","year":"2016","unstructured":"Sugimoto M, Ito S, Mashima K, Umino K, Minakata D, Nakano H, et al. Retrospective evaluation of the MEAM regimen as a conditioning regimen before autologous peripheral blood stem cell transplantation for lymphoma in two centers with different dosing schedules of melphalan. Ann Hematol. 2016;95:1513\u20139.","journal-title":"Ann Hematol."}],"container-title":["International Journal of Hematology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12185-019-02791-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12185-019-02791-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12185-019-02791-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,12,12]],"date-time":"2020-12-12T00:52:10Z","timestamp":1607734330000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12185-019-02791-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12,13]]},"references-count":19,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,3]]}},"alternative-id":["2791"],"URL":"https:\/\/doi.org\/10.1007\/s12185-019-02791-y","relation":{},"ISSN":["0925-5710","1865-3774"],"issn-type":[{"type":"print","value":"0925-5710"},{"type":"electronic","value":"1865-3774"}],"subject":[],"published":{"date-parts":[[2019,12,13]]},"assertion":[{"value":"28 August 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 November 2019","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 December 2019","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 December 2019","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}